SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,011 | -45.4% | 13,985 | +2.2% | 0.00% | – |
| Q1 2024 | $9,175 | +23.4% | 13,690 | 0.0% | 0.00% | – |
| Q4 2023 | $7,438 | -9.4% | 13,690 | 0.0% | 0.00% | – |
| Q3 2023 | $8,211 | -57.0% | 13,690 | -6.8% | 0.00% | – |
| Q2 2023 | $19,097 | -64.1% | 14,690 | -51.4% | 0.00% | – |
| Q1 2023 | $53,166 | +5.6% | 30,208 | +88.3% | 0.00% | – |
| Q4 2022 | $50,366 | -31.0% | 16,040 | +7.1% | 0.00% | – |
| Q3 2022 | $73,000 | +19.7% | 14,979 | +0.9% | 0.00% | – |
| Q2 2022 | $61,000 | -29.1% | 14,840 | 0.0% | 0.00% | – |
| Q1 2022 | $86,000 | -29.5% | 14,840 | -8.8% | 0.00% | – |
| Q4 2021 | $122,000 | -12.9% | 16,269 | +4.4% | 0.00% | – |
| Q3 2021 | $140,000 | -14.6% | 15,590 | +13.9% | 0.00% | – |
| Q2 2021 | $164,000 | -17.2% | 13,690 | -13.5% | 0.00% | – |
| Q1 2021 | $198,000 | -19.8% | 15,820 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $247,000 | +65.8% | 15,820 | 0.0% | 0.00% | – |
| Q3 2020 | $149,000 | +10.4% | 15,820 | +4.6% | 0.00% | – |
| Q2 2020 | $135,000 | -83.9% | 15,120 | -88.6% | 0.00% | -100.0% |
| Q1 2020 | $840,000 | -77.1% | 132,133 | -69.9% | 0.00% | -72.7% |
| Q4 2019 | $3,669,000 | +972.8% | 438,382 | +1058.9% | 0.01% | +1000.0% |
| Q3 2019 | $342,000 | -42.3% | 37,829 | -31.3% | 0.00% | -50.0% |
| Q2 2019 | $593,000 | +115.6% | 55,104 | +91.1% | 0.00% | +100.0% |
| Q1 2019 | $275,000 | +3.0% | 28,839 | +23.9% | 0.00% | 0.0% |
| Q4 2018 | $267,000 | -53.1% | 23,284 | -30.7% | 0.00% | -50.0% |
| Q3 2018 | $569,000 | +31.7% | 33,584 | +10.4% | 0.00% | 0.0% |
| Q2 2018 | $432,000 | +118.2% | 30,413 | +192.1% | 0.00% | +100.0% |
| Q1 2018 | $198,000 | +607.1% | 10,413 | +232.5% | 0.00% | – |
| Q2 2017 | $28,000 | +460.0% | 3,132 | +213.2% | 0.00% | – |
| Q1 2017 | $5,000 | -28.6% | 1,000 | -33.3% | 0.00% | – |
| Q3 2016 | $7,000 | +75.0% | 1,500 | +275.0% | 0.00% | – |
| Q3 2013 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |